STEQEYMA® (ustekinumab-stba) is Celltrion's biosimilar to STELARA® (ustekinumab), which was launched on March 12, 2025 Celltrion's adalimumab-aaty was previously added to the Costco Member Prescription Program in August 2024 JERSEY CITY, N.J., March 27, 2025 /PRNewswire/ -- Celltrion, Inc....
Read More Details
Finally We wish PressBee provided you with enough information of ( Celltrion's STEQEYMA® (ustekinumab-stba), now added to the Costco Member Prescription Program )
Also on site :
- Amazon Is Selling a 'Lovely' $70 Patio Umbrella for Only $30, and Shoppers Love That It’s 'Weather-Resistant'
- Dakota Johnson Says ‘Madame Web’ Flop ‘Wasn’t My Fault’: Decisions Are Made in Hollywood by ‘People Who Don’t Have a Creative Bone in Their Body’
- Is Lucky Leaving 'General Hospital'?